194 related articles for article (PubMed ID: 1872331)
21. Effects of conjugated equine estrogen with and without three different progestogens on lipoproteins, high-density lipoprotein subfractions, and apolipoprotein A-I.
Miller VT; Muesing RA; LaRosa JC; Stoy DB; Phillips EA; Stillman RJ
Obstet Gynecol; 1991 Feb; 77(2):235-40. PubMed ID: 1846437
[TBL] [Abstract][Full Text] [Related]
22. [Postmenopausal women: changes in plasma lipids with different estrogen replacement therapies].
Blumel JE; Brandt A; Garabagno A; Cubillos M; Lozano A
Rev Med Chil; 1990 Apr; 118(4):382-7. PubMed ID: 2133147
[TBL] [Abstract][Full Text] [Related]
23. Postmenopausal estrogen and androgen replacement and lipoprotein lipid concentrations.
Sherwin BB; Gelfand MM; Schucher R; Gabor J
Am J Obstet Gynecol; 1987 Feb; 156(2):414-9. PubMed ID: 3826177
[TBL] [Abstract][Full Text] [Related]
24. Comparison of effects of continuous combined transdermal with oral estrogen and oral progestogen replacement therapies on serum lipoproteins and compliance.
Erenus M; Karakoç B; Gürler A
Climacteric; 2001 Sep; 4(3):228-34. PubMed ID: 11588947
[TBL] [Abstract][Full Text] [Related]
25. [Parameters of lipid metabolism in postmenopausal women on oral or transdermal hormone replacement with or without progesterone].
Foth D; Römer T; Benthin A
Zentralbl Gynakol; 2000; 122(9):483-8. PubMed ID: 11050765
[TBL] [Abstract][Full Text] [Related]
26. Effects of estropipate treatment on plasma lipids and lipoprotein lipid composition in postmenopausal women.
Bagdade JD; Subbaiah PV
J Clin Endocrinol Metab; 1991 Feb; 72(2):283-6. PubMed ID: 1991799
[TBL] [Abstract][Full Text] [Related]
27. Effects of progestogen on lipids, lipoproteins and apolipoproteins during transdermal estrogen replacement therapy with and without medroxyprogesterone acetate.
Castelo-Branco C; Casals E; Sanllehy C; Duran M; Fortuny A; Vanrell JA
J Reprod Med; 1996 Nov; 41(11):833-8. PubMed ID: 8951134
[TBL] [Abstract][Full Text] [Related]
28. Three-year study of estrogen alone versus combined with progestin in postmenopausal women with or without hypercholesterolemia.
Sanada M; Nakagawa H; Kodama I; Sakasita T; Ohama K
Metabolism; 2000 Jun; 49(6):784-9. PubMed ID: 10877207
[TBL] [Abstract][Full Text] [Related]
29. Hormone replacement therapy and lipoprotein changes during early menopause.
Egeland GM; Kuller LH; Matthews KA; Kelsey SF; Cauley J; Guzick D
Obstet Gynecol; 1990 Nov; 76(5 Pt 1):776-82. PubMed ID: 2170887
[TBL] [Abstract][Full Text] [Related]
30. Effect of continuous combined estrogen and desogestrel hormone replacement therapy on serum lipids and lipoproteins.
Marsh MS; Crook D; Whitcroft SI; Worthington M; Whitehead MI; Stevenson JC
Obstet Gynecol; 1994 Jan; 83(1):19-23. PubMed ID: 8272301
[TBL] [Abstract][Full Text] [Related]
31. Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives.
Haarbo J; Hassager C; Jensen SB; Riis BJ; Christiansen C
Am J Med; 1991 May; 90(5):584-9. PubMed ID: 1827568
[TBL] [Abstract][Full Text] [Related]
32. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins.
Walsh BW; Schiff I; Rosner B; Greenberg L; Ravnikar V; Sacks FM
N Engl J Med; 1991 Oct; 325(17):1196-204. PubMed ID: 1922206
[TBL] [Abstract][Full Text] [Related]
33. Changes in plasma lipoprotein and apolipoprotein composition in relation to oral versus percutaneous administration of estrogen alone or in cyclic association with utrogestan in menopausal women.
Moorjani S; Dupont A; Labrie F; De Lignieres B; Cusan L; Dupont P; Mailloux J; Lupien PJ
J Clin Endocrinol Metab; 1991 Aug; 73(2):373-9. PubMed ID: 1649840
[TBL] [Abstract][Full Text] [Related]
34. Changes in plasma lipids and lipoproteins associated with starting or stopping postmenopausal hormone replacement therapy. Atherosclerosis Risk in Communities Study.
Folsom AR; McGovern PG; Nabulsi AA; Shahar E; Kahn ES; Winkhart SP; White AD
Am Heart J; 1996 Nov; 132(5):952-8. PubMed ID: 8892766
[TBL] [Abstract][Full Text] [Related]
35. Perimenopausal changes in serum lipids and lipoproteins: a 7-year longitudinal study.
Fukami K; Koike K; Hirota K; Yoshikawa H; Miyake A
Maturitas; 1995 Nov; 22(3):193-7. PubMed ID: 8746876
[TBL] [Abstract][Full Text] [Related]
36. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.
Vrablik M; Fait T; Kovar J; Poledne R; Ceska R
Metabolism; 2008 Aug; 57(8):1088-92. PubMed ID: 18640386
[TBL] [Abstract][Full Text] [Related]
37. Effects on lipids and lipoproteins in women treated with oestradiol and progesterone.
Darj E; Crona N; Nilsson S
Maturitas; 1992 Dec; 15(3):209-15. PubMed ID: 1465034
[TBL] [Abstract][Full Text] [Related]
38. Serum lipoprotein responses during active and stable weight reduction in reproductive obese females.
Friedman CI; Falko JM; Patel ST; Kim MH; Newman HA; Barrows H
J Clin Endocrinol Metab; 1982 Aug; 55(2):258-62. PubMed ID: 7085852
[TBL] [Abstract][Full Text] [Related]
39. Effect of oral and transdermal hormone replacement therapy on lipid profile and Lp(a) level in menopausal women with hypercholesterolemia.
Perrone G; Stefanutti C; Galoppi P; Anelli G; Capri O; Lucani G; Vivenzio A; Mazzarella B; Zichella L
Int J Fertil Menopausal Stud; 1996; 41(6):509-15. PubMed ID: 9010744
[TBL] [Abstract][Full Text] [Related]
40. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C
Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]